Clinical Trial Update: Study of ORL-1M (D-mannose) in Patients With CDG-Ib [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update for ORL-1M (D-mannose) in patients with Congenital disorder of glycosylation type Ib.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Disorder of Glycosylation Type Ib

Drugs mentioned

• ORL-1M (D-mannose) (D-mannose)

Snippet

Sponsor: Orpha Labs | Conditions: CDG Ib | Phase 1, Phase 2 | Status: UNKNOWN